Enteric fever, encompassing both typhoid and paratyphoid fever, remains a significant health concern worldwide, particularly in developing countries. Rapid diagnosis and appropriate management are critical to reduce morbidity and mortality associated with this disease.
Traditional diagnostic methods, such as blood culture and Widal test, have limitations in terms of sensitivity, specificity, and turnaround time. Recent advancements have led to the development of molecular diagnostic tests like Polymerase Chain Reaction (PCR) and Nucleic Acid Amplification Tests (NAATs), which offer improved sensitivity and specificity, and faster results.
Increasing antimicrobial resistance, particularly to fluoroquinolones and third-generation cephalosporins, has complicated the management of enteric fever. This necessitates the use of culture and sensitivity tests to guide antibiotic therapy. Empiric treatment should now consider the local resistance patterns.
Vaccination plays a pivotal role in the management of enteric fever. The World Health Organization recommends the use of Ty21a and Vi polysaccharide vaccines in endemic areas. The newer conjugate vaccines, which have a longer duration of protection and can be given to younger children, are promising additions to the prevention strategy.
Supportive care, including hydration and antipyretics, remains a mainstay of treatment. In severe or complicated cases, hospitalization may be required. Post-treatment follow-up is crucial to ensure complete resolution of the disease and to monitor for potential complications.
An updated approach to the diagnosis and management of enteric fever includes the use of advanced diagnostic techniques, consideration of local antimicrobial resistance patterns, vaccination, and comprehensive patient care. As the disease landscape changes, it is essential for clinicians to stay informed about the latest developments to provide the best care for their patients.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation